These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8856756)

  • 1. Efforts of pharmacy to reduce antibiotic resistance.
    Klem C; Dasta JF
    New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive?
    Paterson DL; Rice LB
    Clin Infect Dis; 2003 Apr; 36(8):1006-12. PubMed ID: 12684913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The participation of pharmacist in antibiotic related activities of Hungarian hospitals and intensive care units].
    Benko R; Matuz M; Hajdú E; Peto Z; Hegedus A; Bogár L; Soós G
    Acta Pharm Hung; 2009; 79(2):57-62. PubMed ID: 19634635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical results and costs due to improved antibiotics policies].
    Gyssens IC; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2361-4. PubMed ID: 10590774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?
    Kollef MH
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S82-8. PubMed ID: 16894520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic Use at German University Hospitals (Project INTERUNI-II). Results for Medical Intensive Care, Hematology-Oncology, and Other Medical Service Areas].
    de With K; Bergner J; Bühner R; Dörje F; Gonnermann C; Haber M; Hartmann M; Rothe U; Strehl E; Steib-Bauert M; Kern WV
    Med Klin (Munich); 2004 Jul; 99(7):347-54. PubMed ID: 15322713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
    MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
    J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.
    Geissler A; Gerbeaux P; Granier I; Blanc P; Facon K; Durand-Gasselin J
    Intensive Care Med; 2003 Jan; 29(1):49-54. PubMed ID: 12528022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can one use probabilistic protocols for antibiotic therapy in intensive care units?].
    Bourdain N; Lepape A; Galzot F; Lamy B; Haessler D; Chomarat M; Grozel JM; Banssillon V
    Pathol Biol (Paris); 1999 May; 47(5):584-8. PubMed ID: 10418047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise.
    Erlandsson M; Burman LG; Cars O; Gill H; Nilsson LE; Walther SM; Hanberger H;
    Scand J Infect Dis; 2007; 39(1):63-9. PubMed ID: 17366015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance: consideration as an adverse drug event.
    Martin SJ; Micek ST; Wood GC
    Crit Care Med; 2010 Jun; 38(6 Suppl):S155-61. PubMed ID: 20502169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diversity of antibiotic use on the development of antimicrobial resistance.
    Sandiumenge A; Diaz E; Rodriguez A; Vidaur L; Canadell L; Olona M; Rue M; Rello J
    J Antimicrob Chemother; 2006 Jun; 57(6):1197-204. PubMed ID: 16565158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical choices of antibiotics: judging judicious use.
    Steinberg I
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1178-88. PubMed ID: 11187441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?
    Balabanova Y; Fedorin I; Kuznetsov S; Graham C; Ruddy M; Atun R; Coker R; Drobniewski F
    J Antimicrob Chemother; 2004 Sep; 54(3):673-9. PubMed ID: 15317742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care.
    Sintchenko V; Iredell JR; Gilbert GL; Coiera E
    J Am Med Inform Assoc; 2005; 12(4):398-402. PubMed ID: 15802478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial stewardship.
    Fishman N
    Am J Med; 2006 Jun; 119(6 Suppl 1):S53-61; discussion S62-70. PubMed ID: 16735152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance in the intensive care unit: impact of new patterns.
    McGowan J; Tenover F
    Int J Clin Pract Suppl; 1998 Jun; 95():14-22. PubMed ID: 9796551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.